Bio Pharma Dive

FEBRUARY 27, 2023

Digital transformation has much to offer life sciences as well as healthcare — and the synergies between the two can further optimize the power of digital health, clinical trials and patient outcomes.

Life Science 267

Life Science Clinical Trials Clinical Trials Trials 267

Worldwide Clinical Trials

AUGUST 10, 2023

I was fortunate to have the opportunity to attend Psychedelic Science 2023 during the third week of June in Denver, Colorado. The post 3 Key Takeaways from Psychedelic Science 2023 appeared first on Worldwide Clinical Trials. Reflecting back on my conference experience, there are three key takeaways that stand out: 1.

Clinical Trials 246

Clinical Trials Clinical Trials Trials Clinical Research 246

Pharmaceutical Technology

APRIL 22, 2024

Wave Life Sciences Ltd patent reveals a groundbreaking method for synthesizing high-purity oligonucleotides with increased yields. Learn more about this innovative process now!

Life Science 130

Life Science 130

Pharmaceutical Technology

APRIL 20, 2023

European life sciences venture capital firm Forbion has raised €1.35bn ($1.47bn) across its two new funds. The Forbion Growth Opportunities Fund II provides support to the expansion of late-stage life sciences companies. The latest fundraising brings the total funds managed by the company to €3bn ($3.28bn).

Life Science 246

Life Science Marketing Development 246

Pharmaceutical Technology

APRIL 1, 2024

Discover the groundbreaking patent by Gilead Sciences Inc for compounds to treat HIV infection, including specific chemical formulas and pharmaceutical compositions. Learn more about this innovative approach to combating the virus.

130

130

pharmaphorum

FEBRUARY 5, 2024

Data science in healthcare is transforming the industry, from drug discovery to patient care. Learn about the role of data, artificial intelligence (AI), and the impact of initiatives like the NHS Datastore in revolutionising healthcare outcomes.

Drugs 124

Drugs 124

Pharmaceutical Technology

MARCH 5, 2024

The UK Government announced plans to bolster the UK life science manufacturing industry through increased investment.

Life Science 130

Life Science Manufacturing 130

pharmaphorum

MARCH 8, 2024

Celebrate International Women’s Day by learning about Miruna Sasu, a prominent female figure in the life sciences field and CEO of COTA. Explore how the company uses AI in the oncology space.

Life Science 117

Life Science 117

BioPharma Reporter

APRIL 23, 2024

At CPhI North America, Quotient Sciences is looking forward to reconnecting with its customers and giving them a preview of how we are looking to expand Translational Pharmaceutics further within the US.

Development 99

Development Drugs Regulation Marketing 99

Pharmaceutical Technology

JANUARY 23, 2024

Inhalation Sciences has entered into a collaboration with Germany-based Actarmo Medical for respiratory drug development services.

Drugs 130

Drugs Development 130

pharmaphorum

MARCH 8, 2024

Angie Franks is a prominent female figure in the life sciences industry and perfect to highlight on International Women's Day. Learn more about her contributions and achievements in healthcare and technology.

Life Science 114

Life Science 114

Pharmaceutical Technology

APRIL 14, 2023

Biotechnology company Tiziana Life Sciences has revealed plans to assess intranasal foralumab as a potential treatment for long Covid. Tiziana Life Sciences chief medical officer Matthew Davis said: “We anticipate entering into a Phase 2a placebo-controlled clinical trial upon successful feedback from the FDA.

Life Science 246

Life Science Clinical Trials Clinical Trials Trials 246

Bio Pharma Dive

DECEMBER 11, 2023

Research from Everest Group shows how life sciences leaders are investing in process mining to speed time-to-market, improve regulatory compliance and drive innovation.

Life Science 150

Life Science Compliance Marketing Research 150

Pharmaceutical Technology

OCTOBER 12, 2023

Astria Therapeutics has signed a global exclusive agreement to license Ichnos Sciences’ OX40 portfolio for treating atopic dermatitis (AD).

Licensing 130

Licensing Licensing 130

Bio Pharma Dive

DECEMBER 12, 2022

Learn about the investment landscape for life science companies, heading into 2023.

Life Science 257

Life Science 257

Pharmaceutical Technology

FEBRUARY 12, 2024

Super Bowl LVIII saw Astellas run awareness for hot flashes and Pfizer touchdown with the history of science.

130

130

Bio Pharma Dive

APRIL 19, 2023

Forbion and Gilde Healthcare raised a combined $2 billion across their respective funds to invest in emerging biotech and life sciences companies.

Life Science 180

Life Science 180

Pharma Mirror

OCTOBER 16, 2023

The post Quotient Sciences Appoints Thierry Van Nieuwenhove as New CEO appeared first on Pharma Mirror Magazine. Thierry succeeds Mark Egerton who, after 18 years of successfully leading Quotient as CEO, is retiring from executive life.

Manufacturing 130

Manufacturing Development Drugs 130

XTalks

APRIL 24, 2024

Science Over Sensationalism The NCA insists on a science-based approach to evaluating the legitimacy of food additive bans. As more states opt out of food additive bans, it’s clear that a movement grounded in science and expertise is gaining momentum against the tide of misinformation.

Regulation 96

Regulation FDA Approval Drugs 96

Pharmaceutical Technology

NOVEMBER 7, 2023

The UK National Institute for Health and Care Excellence (NICE) unveils refreshed support service, NICE Advice, for the life sciences sector.

Life Science 130

Life Science 130

BioSpace

MARCH 18, 2024

BioSpace's 2024 Salary Report explores the average salaries and salary trends of life sciences professionals.

Life Science 110

Life Science 110

Pharmaceutical Technology

SEPTEMBER 15, 2023

Charles River has signed a multi-programme collaboration agreement with Related Sciences (RS) for the AI-powered drug platform, Logica.

Drugs 147

Drugs 147

Pharma Times

APRIL 17, 2024

Both companies will facilitate career progression while advancing the life sciences industry

Life Science 111

Life Science Drugs Research 111

BioSpace

APRIL 17, 2024

The first Bioversity cohort includes several graduates placed at Massachusetts life sciences companies.

Life Science 102

Life Science 102

Pharmaceutical Technology

OCTOBER 24, 2023

INVO Bioscience has signed an agreement to acquire NAYA Biosciences to establish a publicly traded life science company.

Life Science 130

Life Science 130

Drug Patent Watch

APRIL 24, 2024

Annual Drug Patent Expirations for SUNLENCA Sunlenca is a drug marketed by Gilead Sciences Inc and is included in two NDAs. It is available from one supplier. There are four… Source

Drugs 59

Drugs Marketing 59

XTalks

FEBRUARY 8, 2024

As we commemorate the International Day of Women and Girls in Science 2024, it’s a moment to reflect on and celebrate the vital contributions of women and girls in the spheres of science and technology. Facing the Gender Gap The underrepresentation of women in science is a persistent issue.

Life Science 105

Life Science Scientist Gene Editing Research 105

Cloudbyz

MARCH 17, 2024

In the dynamic world of life sciences, where innovation is paramount, the integration of cutting-edge technologies is crucial for accelerating clinical operations and driving breakthroughs in healthcare. Salesforce’s recent announcement of its Life Sciences Cloud marks a significant stride towards this goal.

Life Science 72

Life Science Clinical Trials Clinical Trials Trials 72

pharmaphorum

OCTOBER 17, 2023

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert Krystle Buntemeyer, CEO of SCORR Marketing, about the trends and changes for health sciences marketing over the past few years.

Marketing 113

Marketing Life Science 113

XTalks

FEBRUARY 15, 2024

In the life sciences, countless Black scientists, researchers and medical professionals have made groundbreaking discoveries that have significantly advanced our understanding of biology and medicine. February is Black History Month, a time dedicated to celebrating the achievements and contributions of African Americans throughout history.

Life Science 115

Life Science Scientist Protein Research 115

BioPharma Reporter

MAY 1, 2024

We spoke with RenÃe about her journey from investment banking to science and the joy of bringing therapies to patients. RenÃe Aguiar-Lucander, CEO of Calliditas, is driving the advancement and launch of TARPEYO â the companyâs medication targeting rare disease IgA nephropathy.

Drug Delivery 59

Drug Delivery Drugs 59

pharmaphorum

MARCH 18, 2024

Discover the top 7 challenges faced by pharmaceutical and life sciences companies in achieving patient-centricity and engaging healthcare professionals (HCPs). Explore strategies to overcome these obstacles for successful outreach efforts.

Life Science 116

Life Science 116

Pharma Times

SEPTEMBER 28, 2023

Initiative has been designed to support career advancement for women across the life sciences - News - PharmaTimes

Life Science 146

Life Science 146

Bio Pharma Dive

OCTOBER 25, 2023

This podcast series explores how life sciences companies can bolster their cybersecurity while growing their business.

Life Science 150

Life Science 150

BioPharma Reporter

APRIL 24, 2024

From a child's chemistry set given to her by her grandfather to watching Open University maths programs, Karen Ooms seemed destined for a career in science.

Research 105

Research 105

pharmaphorum

JANUARY 25, 2024

Discover the role of GenAI in life sciences in 2024. Explore how artificial intelligence and machine learning techniques like GenAI are revolutionising drug development, diagnostics, and research. Learn how industry leaders, including Google, are leveraging GenAI to advance healthcare and enhance patient outcomes.

Life Science 112

Life Science Development Drugs Research 112

Drug Patent Watch

APRIL 18, 2024

Annual Drug Patent Expirations for VEMLIDY Vemlidy is a drug marketed by Gilead Sciences Inc and is included in one NDA. It is available from one supplier. There are three… Source

Drugs 59

Drugs Marketing 59